EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of YES1 Inhibitors From Approved Drugs Using a Multimodal Deep Learning Framework

Takayoshi Kawabata, Tatsuaki Takeda iD, Yuta Tanaka iD, Soichiro Ushio iD, Akira Miyamoto, Koki Nakagomi, Tomonori Sakai iD, Risa Maruyama, Takashi Makita iD, Hirofumi Hamano, Shinichi Toyooka iD, Yoshito Zamami iD

Molecular Informatics · 2026

DOI: 10.1002/minf.70061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Informatics, 2026. Verfasst von Takayoshi Kawabata und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-yes, Deep Learning, Drug Repositioning, Antineoplastic Agents. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While anti‐human epidermal growth factor receptor 2 (HER2) drugs, including trastuzumab improve the prognosis of patients with HER2‐positive cancers, acquired resistance by cancer cells remains a significant clinical challenge. We had previously reported that YES1 is overexpressed in trastuzumab‐resistant breast and lung cancer cells, and that its inhibition restores trastuzumab sensitivity. However, no approved drug specifically targets YES1. In this study, as a drug repositioning approach aimed at rapid clinical application, we constructed a machine learning model capable of learning the interactions between compounds and target proteins and conducted a screening of approved drugs. The strategy identified chlorpromazine and raloxifene as hit compounds. In vitro validation demonstrated that they effectively inhibited YES1 activation at 15 μM after 48 h. The findings suggested that the identified approved drugs might represent promising therapeutic options for overcoming anti‐HER2 drug resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-yesDeep LearningDrug RepositioningAntineoplastic AgentsProtein Kinase InhibitorsHumansDrug Resistance, NeoplasmCell Line, TumorErb-b2 Receptor Tyrosine KinasesRaloxifene Hydrochloride

Stichwörter der Autor:innen

HER2 resistanceantitumor agentsdrug repositioningdrug resistancevirtual screening

Substanzen

Proto-Oncogene Proteins c-yesYES1 protein, humanAntineoplastic AgentsProtein Kinase InhibitorsErb-b2 Receptor Tyrosine KinasesRaloxifene Hydrochloride

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Department of Pharmacy, Okayama University Hospital, Okayama, Japan.
  • Center for Education in Medicine and Health Sciences, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Department of Pharmaceutical Sciences for Health Crisis Management, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan.
  • Department of Pharmacy, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.
  • Digital Innovation Section, Digital Transformation Promotion Department, Nippon Shinyaku co., Ltd., Kyoto, Japan.

ORCID-Profile: Tatsuaki Takeda, Yuta Tanaka, Soichiro Ushio, Tomonori Sakai, Takashi Makita, Shinichi Toyooka, Yoshito Zamami

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Kawabata, T., Takeda, T., Tanaka, Y., Ushio, S., Miyamoto, A., Nakagomi, K., Sakai, T., Maruyama, R., Makita, T., Hamano, H., Toyooka, S., & Zamami, Y. (2026). Identification of YES1 Inhibitors From Approved Drugs Using a Multimodal Deep Learning Framework. Molecular Informatics. https://doi.org/10.1002/minf.70061

Vancouver

Kawabata T, Takeda T, Tanaka Y, Ushio S, Miyamoto A, Nakagomi K, et al. Identification of YES1 Inhibitors From Approved Drugs Using a Multimodal Deep Learning Framework. Molecular Informatics. 2026. doi:10.1002/minf.70061

BibTeX
@article{Kawabata2026,
  author = {Kawabata, Takayoshi and Takeda, Tatsuaki and Tanaka, Yuta and Ushio, Soichiro and Miyamoto, Akira and Nakagomi, Koki and Sakai, Tomonori and Maruyama, Risa and Makita, Takashi and Hamano, Hirofumi and Toyooka, Shinichi and Zamami, Yoshito},
  title = {Identification of YES1 Inhibitors From Approved Drugs Using a Multimodal Deep Learning Framework},
  journal = {Molecular Informatics},
  year = {2026},
  doi = {10.1002/minf.70061}
}
Kostenlos starten →